1643 — Modern Chinese Medicine Co Cashflow Statement
0.000.00%
- HK$201.00m
- -HK$43.67m
- CNY214.07m
- 68
- 83
- 33
- 69
Annual cashflow statement for Modern Chinese Medicine Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 90.5 | 114 | 124 | 68.3 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1.95 | -0.788 | 5.44 | 0.385 | — |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -51.5 | -58.6 | -9.67 | -66.7 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 42.8 | 57.6 | 126 | 8.48 | — |
Capital Expenditures | -0.544 | -70.5 | -11.7 | -5.1 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.136 | 0.421 | 0.675 | 0.906 | — |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.408 | -70 | -11 | -4.19 | — |
Financing Cash Flow Items | -4.72 | -26.7 | -0.014 | -0.005 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -5.05 | 116 | -8.73 | -0.326 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 37.3 | 103 | 106 | 4.01 | — |